Home > Insider Trading > Filing (0001562180-19-005623)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1517022	Akebia Therapeutics Inc.	AKBA	Pharmaceutical Preparations (2834)	208756903

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1591467	P. John Butler	C/O Akebia Therapeutics, Inc. 245 First Street Cambridge MA 02142	Ceo And President	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-11-20	50,000	$3.44	887,732	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	59,928	Indirect	Held by Dorothy Butler 2019 GRAT
Common Stock	31,047	Indirect	Held by Dorothy Butler Revocable Trust 2007
Common Stock	59,928	Indirect	Held by John Butler 2019 GRAT
Common Stock	31,047	Indirect	Held by John Butler Revocable Trust 2007

Footnotes

The purchase reported in this Form 4 was made on the open market.
The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.22 to $3.65, inclusive. The reporting person undertakes to provide Issuer, any security holder of Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.
Includes 1,500 shares of the Issuer's common stock purchased under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan on June 28, 2019.